1.
Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone. IJBR. 2025;3(4):614-617. doi:10.70749/ijbr.v3i4.859